Skip to main navigation Skip to search Skip to main content

Pediatric Acute Lymphoblastic Leukemia, Version 2.2025

  • Hiroto Inaba
  • , David Teachey
  • , Colleen Annesley
  • , Sandeep Batra
  • , Jill Beck
  • , Susan Colace
  • , Stacy Cooper
  • , Mari Dallas
  • , Satiro De Oliveira
  • , Kara Kelly
  • , Carrie Kitko
  • , Mira Kohorst
  • , Matthew Kutny
  • , Norman Lacayo
  • , Cathy Lee-Miller
  • , Kathleen Ludwig
  • , Lisa Madden
  • , Kelly Maloney
  • , David Mangum
  • , Stephanie Massaro
  • David McCall, Perry Morocco, Brad Muller, Lindsey Murphy, Valentina Nardi, Jenna Rossoff, Laura Schuettpelz, Bijal Shah, Jessica Sun, Victor Wong, Gregory Yanik, Ajibola Awotiwon, Katie Stehman
  • University of Tennessee Health Science Center
  • University of Pennsylvania
  • Seattle Children's Hospital
  • Indiana University Bloomington
  • University of Nebraska Medical Center
  • Ohio State University
  • Johns Hopkins University
  • Case Western Reserve University
  • University of California at Los Angeles
  • Vanderbilt University
  • Mayo Clinic Rochester, MN
  • University of Alabama at Birmingham
  • Stanford University
  • University of Wisconsin-Madison
  • Children's Medical Center Dallas
  • University of California at Davis
  • University of Colorado Anschutz Medical Campus
  • University of Utah
  • Yale University
  • University of Texas MD Anderson Cancer Center
  • The University of Chicago
  • City of Hope National Med Center
  • Dana-Farber Cancer Institute
  • Northwestern University
  • Washington University St. Louis
  • Moffitt Cancer Center
  • Duke University
  • Rady Children's Hospital
  • University of Michigan, Ann Arbor
  • National Comprehensive Cancer Network

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Acute Lymphoblastic Leukemia (ALL) were developed as a result of meetings convened by a multidisciplinary panel of pediatric ALL experts, with the goal of providing recommendations on standard treatment approaches based on current evidence. The NCCN Guidelines for pediatric ALL focus on risk assessment and stratification of risk-adapted therapy; treatment strategies for BCR::ABL1 (Philadelphia chromosome [Ph])-negative and BCR::ABL1-positive B-cell lineage, T-cell lineage, and infant ALL; and supportive care considerations. This selection from the NCCN Guidelines for pediatric ALL focuses on the diagnosis of and management of pediatric T-ALL.

Original languageEnglish
Pages (from-to)41-62
Number of pages22
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume23
Issue number2
DOIs
StatePublished - Feb 2025

Fingerprint

Dive into the research topics of 'Pediatric Acute Lymphoblastic Leukemia, Version 2.2025'. Together they form a unique fingerprint.

Cite this